Spyre Therapeutics, Inc.

Equities

SYRE

US00773J2024

Market Closed - Nasdaq Other stock markets 04:00:00 2026-04-17 pm EDT			5-day change	1st Jan Change
73.01 ^USD	+4.75%		+42.35%	+122.86%

Apr. 16	Spyre Therapeutics Closes $463.5 Million Stock Offering	MT
Apr. 15	Exchange-Traded Funds, Equity Futures Higher Pre-Bell Wednesday as Investors Turn to Corporate Earnings	MT

Transcript : Spyre Therapeutics, Inc. Presents at Leerink Global Healthcare Conference 2026, Mar-09-2026 08

Published on 03/11/2026 at 01:43 am EDT

S&P Capital IQ

Presenter Speech
Thomas Smith (Analysts)

Good morning, everyone. Thanks for joining us here at the Leerink Partners Global Healthcare Conference. My name is Tom Smith. I'm one of the senior biotech

This article is reserved for subscribers

Unlock the article : SUBSCRIBE!

Already a customer? Log In

Latest news about Spyre Therapeutics, Inc.

Apr. 16	Spyre Therapeutics Closes $463.5 Million Stock Offering	MT
Apr. 15	Exchange-Traded Funds, Equity Futures Higher Pre-Bell Wednesday as Investors Turn to Corporate Earnings	MT
Apr. 15	Spyre Therapeutics Prices Upsized $403 Million Share Offering	MT
Apr. 14	Spyre Therapeutics announces pricing of upsized $403 million public offering of common stock	RE
Apr. 14	Mizuho Boosts Price Target on Spyre Therapeutics to $84 From $53, Keeps Outperform Rating	MT
Apr. 14	Deutsche Bank Adjusts Spyre Therapeutics PT to $88 From $55, Maintains Buy Rating	MT
Apr. 13	Spyre Therapeutics announces proposed public offering of its common stock	RE
Apr. 13	Spyre Therapeutics Inc suspends and terminates ATM prospectus for at-the-market offering effective April 13, 2026 - SEC filing	RE
Apr. 13	Spyre Therapeutics Launches $300 Million Stock Offering	MT
Apr. 13	Spyre Therapeutics, Inc. Announces Potential Best-In-Class SPY001 Induction Results From Skyline Trial In Moderate-To-Severe Ulcerative Colitis Patients	CI
Apr. 13	Top Midday Gainers	MT
Apr. 13	Wedbush Adjusts Price Target on Spyre Therapeutics to $80 From $65, Maintains Outperform Rating	MT
Apr. 13	Global markets live: Goldman Sachs, Baker Hughes, Conagra Brands, Microsoft, Lufthansa…
Apr. 13	Spyre Therapeutics, Inc. - Special Call
Apr. 13	Exchange-Traded Funds, Equity Futures Lower Pre-Bell Monday as Trump Prepares to Block Strait of Hormuz	MT